Top 15 diseases featured in the most publications
Published scientific articles can provide insight into the healthcare industry’s ongoing trends and upcoming developments. By analyzing publications across the industry, healthcare organizations can understand who are the leading and emerging experts within a therapeutic area, which issues are shaping the field, and which diseases are drawing the greatest attention.
The following table lists the top 15 diseases featured in the most publications in 2022. We analyzed more than 1 million publications from the Monocl product suite to obtain this data, including clinical trial articles, review articles, and guideline articles. We also utilized a keyword hierarchy to identify terms within the publications and tag them with the specific disease state.
|Number of publications
|Diabetes mellitus, type 2
Which diseases were featured in the most publications?
In 2022 alone, 233,419 publications were published on the 15 leading disease states. With more than 1 million publications available in 2022, nearly 20% were focused on the top 15 diseases. COVID-19 ranked first, with 50,000 more publications then the second ranked disease, neoplasms.
COVID-19 is a contagious disease caused by a virus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China in December 2019. The disease quickly spread worldwide, resulting in the COVID-19 pandemic. Given the prevalence of the COVID-19 pandemic, it’s no surprise that this disease tops the list of research areas.
Digging into the second most researched disease, neoplasms are a type of abnormal or excessive growth of tissue. Neoplasms have a significant number of related topics associated with this higher-level term, including cysts and precancerous conditions.
Neoplasms have been the subject of regular publications since 2000, with steady increases in the number of articles each year until 2020. Over the last two years, publications focused on neoplasms have declined.
Healthcare Insights are developed with healthcare commercial intelligence from the Definitive Healthcare platform.
Monocl ExpertInsight enables you to view publications in a timeline view, based on disease state, proteins and chemicals, techniques, anatomy, or organisms. This view extends back as far as 1990, so you can identify emerging topics or trends on a broad scale. Knowing how many publications each year are focused on a specific topic supports biopharma organizations’ ongoing search for new potential markets or drug expansion opportunities. Want even more insights? Book a demo today to see the latest healthcare commercial intelligence on publications, facilities, disease states, and providers.